AstraZeneca's Coronavirus Vaccine Trial Can Continue In The US

Views 6

AstraZeneca and the University of Oxford got the go-ahead to restart their US coronavirus vaccine trials.
The late-stage trial was stopped due to a possible adverse reaction in one of the participants.
On September 6 AstraZeneca reported a "suspected serious adverse reaction".
According to Business Insider, the reaction occurred in a UK-based participant.
The UK resumed clinical trials for AstraZeneca and the University of Oxford vaccines in September.
The trials in Japan resumed earlier this month.

Share This Video


Download

  
Report form
RELATED VIDEOS